Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Diagnostic Utility of MRI in Intracerebral Hemorrhage

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2012 by Stanford University.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Stanford University Identifier:
First received: August 9, 2006
Last updated: June 12, 2012
Last verified: June 2012
The overall aim of this project is to prospectively determine whether MRI can improve the conventional neuroradiological evaluation (CT with or without cerebral angiography) of patients with a spontaneous ICH or IVH. The study design will also allow us to identify the added benefit of specific MR sequences and repeat MRI in the chronic stage, thereby allowing us to prospectively determine their value in a consecutive series of patients. This information should have a major impact on the management of these patients by providing data on the diagnostic yield of routine MRI in patients presenting with a wide variety of causes for ICH or IVH. These data will help guide the diagnostic evaluation and the management of brain hemorrhage patients in the future.

Cerebral Hemorrhage

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diagnostic Utility of MRI in Intracerebral Hemorrhage

Resource links provided by NLM:

Further study details as provided by Stanford University:

Estimated Enrollment: 160
Study Start Date: June 2006
Estimated Study Completion Date: April 2013
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
A total of 180 ICH or IVH patients will be studied. All patients will be inpatients admitted to the Stanford Stroke Center, a multidisciplinary referral center for the treatment of acute stroke. Consecutive patients will be enrolled provided they meet the inclusion and exclusion criteria and that they or a legally authorized representative give informed consent.

Inclusion Criteria:

A. Men and non-pregnant women, at least 18 years of age.

B. Patients with an ICH or IVH admitted to Stanford University Medical center within 48 hours of symptom onset.

C. Ability to undergo MRI.

Exclusion Criteria:

A. Patients with a known (preexisting) source for ICH, for example a known untreated arterio-venous malformation.

B. Patients receiving investigational drug therapies or procedures prior to MRI scanning.

C. Glasgow coma scale (GCS) score < 6 in the absence of sedating medications.

D. Informed consent cannot be obtained either directly from the patient or from a legally authorized representative.

E. Severe coexisting or terminal systemic disease that limits life expectancy or that may interfere with the conduct of the study

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00363662

Contact: Stephanie M Kemp, BS (650) 723-4481

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Stephanie M Kemp, BS    650-723-4481   
Contact: Eyngorn, MD    (650) 498-7333   
Principal Investigator: Christine Wijman         
Sub-Investigator: Gregory W Albers         
Sub-Investigator: Michael E. Moseley         
Sub-Investigator: Maarten G Lansberg MD, PhD         
Sub-Investigator: Anna K. Finley Caulfield         
Sub-Investigator: Neil Schwartz         
Sub-Investigator: Dr Marion S Buckwalter         
Sub-Investigator: Dr. chitra venkat         
Sub-Investigator: Waimei A Tai, MD         
Sub-Investigator: Jean Marc Olivot, MD         
Sponsors and Collaborators
Stanford University
Principal Investigator: Christine Wijman Stanford University
  More Information

Responsible Party: Stanford University Identifier: NCT00363662     History of Changes
Other Study ID Numbers: 2R01NS034866-08A1 ( US NIH Grant/Contract Award Number )
Study First Received: August 9, 2006
Last Updated: June 12, 2012

Additional relevant MeSH terms:
Cerebral Hemorrhage
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases processed this record on April 24, 2017